Why the study?
Does transport to primary angioplasty reduce the combined clinical end-point of death, reinfarction, or stroke at 30 days in patients with acute myocardial infarction presenting to a community hospital without a catheterization laboratory compared to immediate thrombolysis?
Does transport to primary angioplasty reduce the combined clinical end-point of death, reinfarction, or stroke at 30 days in patients with acute myocardial infarction presenting to a community hospital without a catheterization laboratory compared to immediate thrombolysis?
Transferring patients with acute myocardial infarction from community hospitals to tertiary centers for primary angioplasty is safe and significantly reduces the 30-day composite of death, reinfarction, or stroke compared to onsite thrombolysis.
Supports transfer for primary PCI over thrombolysis in community hospitals; confirms lower 30-day composite events in STEMI.
Transferring patients from community hospitals to a tertiary angioplasty centre in the acute phase of myocardial infarction is feasible and safe. This strategy is associated with a significant reduction in the incidence of reinfarction and the combined clinical end-point of death/reinfarction/stroke at 30 days when compared to standard thrombolytic therapy at the community hospital.
No takes yet. Share an insight, caveat, or question.
Petr Widimský (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: